Table of Contents Table of Contents
Previous Page  313 / 1138 Next Page
Information
Show Menu
Previous Page 313 / 1138 Next Page
Page Background

Abscopal immune effects

3 x 9.5 Gy

Postow et al:

NEJM 2012;366:925

Ipilumimab is an antibody aginst the T-cell CLTA4 receptor.

Inhibits the negative feed-back of cytotoxic T-lymphocytes

1 … 308 309 310 311 312 313 314 315 316 317 318 319 … 1138  FlippingBook